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The aim of this study is to identify current knowledge gaps in fate, exposure, and toxicity of engineered nanomaterials (ENMs),
highlight research gaps, and suggest future research directions. Humans and other living organisms are exposed to ENMs during
production or use of products containing them. To assess the hazards of ENMs, it is important to assess their physiochemical
properties and try to relate them to any observed hazard. However, the full determination of these relationships is currently limited
by the lack of empirical data.Moreover,most toxicity studies donot use realistic environmental exposure conditions for determining
dose-response parameters, affecting the accurate estimation of health risks associated with the exposure to ENMs. Regulatory
aspects of nanotechnology are still developing and are currently the subject of much debate. Synthesis of available studies suggests
a number of open questions. These include (i) developing a combination of different analytical methods for determining ENM
concentration, size, shape, surface properties, and morphology in different environmental media, (ii) conducting toxicity studies
using environmentally relevant exposure conditions and obtaining data relevant to developing quantitative nanostructure-toxicity
relationships (QNTR), and (iii) developing guidelines for regulating exposure of ENMs in the environment.
1. Introduction
Production and demand of engineered nanomaterials
(ENMs) embedded in consumer products are growing
significantly in the current years [1, 2]. ENMs can be directly
released into the air, water, sediment, and soil media during
their manufacturing, use, and disposal [3–9]. Nanosize
particles are also sometimes unintentionally formed, such
as those arising from the combustion of fossil fuels in
motor vehicles and industries [3, 4]. In this review, ENMs
refer to particulate materials having at least one of three
dimensions in the 1–100 nm size range (nanoscale). In
contrast, nanoparticles are particulate materials with all
three dimensions in the nanoscale.
ENMs are currently considered as an emerging class of
environmental contaminants. Recent research advances have
(i) improved analytical capabilities for detecting them in
different environmental media, (ii) increased availability of
related toxicity data, and (iii) increased public awareness.
Nevertheless there are still many open questions that need to
be answered in order to fully understand their origin, fate,
and toxicity.
ENMs pose risk to human health and the environment
via oral, inhalation, and dermal exposure routes [10–15].
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Table 1 summarises the key findings of recent studies related
to their exposure assessment. These studies were selected to
provide information about research trends in the area of risk
assessment of different ENMs by means of different exposure
routes. Most of these studies have focused on the framework
development for (i) estimating exposure doses and risks
from oral and inhalation exposure routes, (ii) prioritising
nanomaterials for monitoring and risk estimating purposes,
and (iii) identifying research strategies for intelligent testing
of ENMs for nanosafety. Furthermore, results of toxicity
studies suggest that ENMs can cross the cell membrane and
induce toxic effects on different organs [16–19]. For example,
TiO
2
nanoparticles have been observed to induce DNA and
chromosomal damage in the liver [13, 20]. These effect-based
studies also indicate that ENMs exert different toxicities in
a particular target organ depending on their properties. This
highlights the need for further investigations related to the
exposure of ENMs.
To estimate the environmental and human health risks
associated with ENM exposure, information about their size,
shape, and the dose-response relation is required [37, 44].
The methodology suggested by the standard United States
National Research Council [45, 46] proposes four steps for
performing environmental andhumanhealth risk assessment
(EHHRA) of chemicals and metals: (i) hazard identification,
(ii) exposure assessment, (iii) dose-response assessment, and
(iv) risk characterisation. A few studies have attempted to
apply some of these steps for estimating risks of exposure to
ENMs (Table 1). However, very few studies have carried out
exhaustive risk assessment process for ENMs, probably due to
the lack of required information on their fate, exposure, and
toxicity.
The aims of this article are to highlight present knowl-
edge gaps in environmental fate, exposure, and toxicity of
ENMs. The suitability of currently available toxicity data in
conducting EHHRA is also analysed. Issues identified in this
study can help in developing efforts for addressing current
data gaps for ENMs which can aid decision makers in the
policy making process.
2. Scope
There are two main sources of nanomaterials in the environ-
ment: natural and anthropogenic.Natural sources include but
are not limited to volcanoes, viruses, ocean spray, dust storms,
bacteria, and bush fires. Anthropogenic sources fall into two
categories: unintentionally produced nanomaterials such as
those from combustion aerosols, particularly motor vehicle
exhaust emission, coal fly ash, and wielding operations and
intentionally produced nanomaterials with tailored proper-
ties.Thesemay include nanowires, nanotubes, quantum dots,
and fullerenes, mostly composed of metals and metal oxides
[47]. In addition, nanoparticles can be incidentally formed
in both of these categories [38]. This review focuses on four
important aspects of the intentionally produced group of
ENMs. These include (i) characterisation and application of
ENMs, (ii) assessment of exposure to ENMs, (iii) hazard
assessment, and (iv) environmental regulations. A literature
review of published reports and journal articles is compiled
to map the existing knowledge and to identify current gaps.
The reviewed studies include only key literature to highlight
the covered topics and do not represent the complete list of
all published studies so far due to the reasons of brevity. The
concluding section presents issues on different aspects and
future research needs.
3. Characterisation and
Application of Nanomaterials
3.1. Characterisation of ENMs. ENMs can be characterised
using different techniques. Microscopy, in particular, has
been exceptionally useful in providing information about the
size and morphology of nanomaterials [48]. Scanning and
transmission electron microscopy (SEM and TEM, resp.),
atomic force microscopy (AFM), scanning probemicroscopy
(SPM), and scanning tunnelling microscopy (STM) have
all been extensively employed to observe morphological,
compositional, and structural features of a wide range of
nanomaterials. SEM is a versatile technique that can deter-
mine the morphology whilst TEM can be used for the
observation of the finest details of the internal structure of
materials [49]. High resolution images of the morphology
and topography of a sample can be obtained and composi-
tional analysis of a material can also be carried out by moni-
toring secondary X-rays produced by the electron-specimen
interaction.
A number of other methods are also available for the
characterisation of nanomaterials in air [50]. These include
their characterisation in terms of particle concentration
and size distribution by the condensation particle counter
(CPC), differential mobility particle sizer (DMPS), differen-
tial mobility spectrometer (DMS), fast mobility particle sizer
(FMPS), electrical low pressure impactor (ELPI), and scan-
ning mobility particle sizer (SMPS) [50, 51], as discussed in
Section 4. The Brunauer, Emmett, and Teller (BET) method
is commonly used to evaluate the gas adsorption data and
generate information about specific surface area and pore size
of various types of nanoparticles [52]. Thermogravimetric
analysis (TG) is conveniently used to determine physical
changes in materials. This technique provides quantitative
measurement of mass change associated with transition and
thermal degradation in the materials [53]. Characteristic
thermogravimetric curves are given for specific materials
and chemical compounds due to unique sequence from
physicochemical reactions occurring over specific temper-
ature ranges and heating rates. Vibrational spectroscopy
techniques, including the Fourier transform infrared (FTIR),
the near-infrared, and the Raman spectroscopy, have also
been used to characterise nanomaterials. For example, Lo´pez-
Lorente et al. [54] recently described the use of G-/D-band
intensity ratios in the Raman spectroscopic measurements
for the determination of the purity of carbon nanotube
samples. In addition, X-ray diffraction is currently being
used for determining crystallinity of nanomaterials [55].This
information is especially important in toxicity studies as
mineralogical phase of nanomaterials can also influence toxic
effects [56].
Journal of Nanomaterials 3
Ta
bl
e
1:
Sa
m
pl
es
um
m
ar
y
of
EN
M
-r
el
at
ed
hu
m
an
eff
ec
ts
an
d/
or
ris
k
as
se
ss
m
en
ts
tu
di
es
.
Re
fe
re
nc
e
Ex
po
su
re
ro
ut
e
EN
M
sc
on
sid
er
ed
St
ud
y
fo
cu
s
M
or
ga
n
[2
1]
N
A
—
D
ev
elo
pm
en
to
fp
re
lim
in
ar
y
fr
am
ew
or
k
fo
rr
isk
an
al
ys
is
an
d
ris
k
m
an
ag
em
en
to
fE
N
M
s
us
in
g
ex
pe
rt
eli
ci
ta
tio
n
an
d
m
en
ta
lm
od
el
lin
g
M
ay
na
rd
an
d
Ku
em
pe
l[
2]
In
ha
lat
io
n
—
Re
vi
ew
of
ai
rb
or
ne
na
no
st
ru
ct
ur
ed
pa
rt
ic
le
sa
nd
oc
cu
pa
tio
na
lh
ea
lth
W
ie
sn
er
et
al
.[
22
]
N
A
—
As
se
ss
m
en
to
fr
isk
so
fm
an
uf
ac
tu
re
d
na
no
m
at
er
ia
ls
Ts
uj
ie
ta
l.
[2
3]
In
ha
lat
io
n
an
d
de
rm
al
—
Re
vi
ew
of
ris
k
as
se
ss
m
en
to
fE
N
M
sd
ue
to
in
ha
lat
io
n
an
d
de
rm
al
ro
ut
es
La
m
et
al
.[
10
]
In
ha
lat
io
n
Ca
rb
on
na
no
tu
be
s
Re
vi
ew
of
ca
rb
on
na
no
tu
be
to
xi
ci
ty
an
d
as
se
ss
m
en
to
fp
ot
en
tia
lo
cc
up
at
io
na
la
nd
en
vi
ro
nm
en
ta
lh
ea
lth
ris
ks
Ka
nd
lik
ar
et
al
.[
24
]
In
ha
lat
io
n
Pa
rt
ic
le
sl
es
st
ha
n
2.
5𝜇
m
in
di
am
et
er
H
ea
lth
ris
k
as
se
ss
m
en
to
fn
an
op
ar
tic
le
su
sin
g
ex
pe
rt
ju
dg
m
en
t
D
an
ko
vi
ce
ta
l.
[1
1]
In
ha
lat
io
n
Fi
ne
an
d
ul
tr
afi
ne
Ti
O
2
Ca
lc
ul
at
io
n
of
ris
k
of
ca
nc
er
us
in
g
do
se
-r
es
po
ns
ei
nf
or
m
at
io
n
fo
rr
at
s
M
ue
lle
ra
nd
N
ow
ac
k
[3
]
N
A
A
g,
Ti
O
2,
an
d
ca
rb
on
na
no
tu
be
s
Ex
po
su
re
m
od
el
lin
g
of
EN
M
si
n
en
vi
ro
nm
en
tu
sin
g
lif
e-
cy
cle
pe
rs
pe
ct
iv
es
Li
ao
et
al
.[
12
]
In
ha
lat
io
n
N
an
o-
/fi
ne
Ti
O
2
M
od
el
-b
as
ed
as
se
ss
m
en
tf
or
hu
m
an
in
ha
lat
io
n
ex
po
su
re
ris
k
as
se
ss
m
en
t
Kr
ol
le
ta
l.
[2
5]
N
A
—
Cu
rr
en
ti
n
vi
tro
m
et
ho
ds
in
EN
M
sr
isk
as
se
ss
m
en
t:
lim
ita
tio
n
an
d
ch
al
le
ng
es
Sh
in
oh
ar
ae
ta
l.
[2
6]
In
ha
lat
io
n
Fu
lle
re
ne
s
Ri
sk
as
se
ss
m
en
t
M
or
im
ot
o
et
al
.[
27
]
In
ha
lat
io
n
Fu
lle
re
ne
s
In
fla
m
m
og
en
ic
eff
ec
to
fw
el
l-c
ha
ra
ct
er
ise
d
fu
lle
re
ne
si
n
in
ha
lat
io
n
an
d
in
tr
at
ra
ch
ea
l
in
st
ill
at
io
n
stu
di
es
Te
rv
on
en
et
al
.[
28
]
N
A
Fu
lle
re
ne
s,
ca
rb
on
na
no
tu
be
s,
C
dS
e,
A
g,
an
d
A
l
Ri
sk
-b
as
ed
cla
ss
ifi
ca
tio
n
sy
ste
m
so
fn
an
om
at
er
ia
ls
O
’B
rie
n
an
d
Cu
m
m
in
s[
29
]
N
A
N
A
D
ev
elo
pm
en
to
fa
th
re
e-
le
ve
lr
isk
as
se
ss
m
en
ts
tr
at
eg
y
fo
rn
an
om
at
er
ia
ls
G
rie
ge
re
ta
l.
[3
0]
N
A
—
St
ud
y
of
cu
rr
en
tr
es
ea
rc
h
pr
io
rit
ie
sf
or
na
no
m
at
er
ia
ls
an
d
re
de
fin
in
g
of
ris
k-
ba
se
d
eff
or
ts
Ch
ris
te
ns
en
et
al
.[
31
]
In
ha
lat
io
n
A
g
In
ve
st
ig
at
io
n
of
fe
as
ib
ili
ty
an
d
ch
al
le
ng
es
as
so
ci
at
ed
w
ith
co
nd
uc
tin
g
H
H
RA
fo
rA
g
EN
M
s
an
d
id
en
tifi
ca
tio
n
of
re
lat
ed
da
ta
ga
ps
Ch
ris
te
ns
en
et
al
.[
32
]
In
ha
lat
io
n
Ti
O
2
In
ve
st
ig
at
io
n
of
fe
as
ib
ili
ty
an
d
ch
al
le
ng
es
as
so
ci
at
ed
w
ith
co
nd
uc
tin
g
H
H
RA
fo
rT
iO
2
EN
M
sa
nd
id
en
tifi
ca
tio
n
of
re
lat
ed
da
ta
ga
ps
G
an
gw
al
et
al
.[
33
]
In
ha
lat
io
n
Ti
O
2
an
d
A
g
M
et
ho
d
de
ve
lo
pm
en
tf
or
de
te
rm
in
in
g
na
no
m
at
er
ia
ls
co
nc
en
tr
at
io
ns
fo
rT
ox
C
as
ti
n
vi
tro
te
sti
ng
fo
ro
cc
up
at
io
na
le
xp
os
ur
ep
ot
en
tia
l
A
na
nd
an
an
d
Ku
m
ar
[3
4]
O
ra
l
Ti
O
2
an
d
A
g
Es
tim
at
io
n
of
ris
k
to
hu
m
an
sd
ue
to
ex
po
su
re
of
EN
M
sd
ur
in
g
in
ad
ve
rt
en
ti
ng
es
tio
n
of
st
re
am
w
at
er
us
in
g
liv
er
ce
ll
lin
e-
ba
se
d
to
xi
ci
ty
da
ta
Jo
hn
so
n
et
al
.[
35
]
O
ra
l
Ti
O
2
St
ud
y
on
fa
te
,b
eh
av
io
ur
,a
nd
en
vi
ro
nm
en
ta
lr
isk
as
so
ci
at
ed
w
ith
su
ns
cr
ee
n
Ti
O
2
EN
M
s;
H
H
RA
co
nd
uc
te
d
fo
ri
ng
es
tio
n
of
Ti
O
2
pa
rt
ic
le
s
Ku
m
ar
et
al
.[
36
]
In
ha
lat
io
n
EN
M
s
Em
iss
io
ns
es
tim
at
es
of
na
no
m
at
er
ia
ls
fro
m
ro
ad
ve
hi
cle
si
n
m
eg
ac
ity
D
el
hi
an
d
as
so
ci
at
ed
he
al
th
im
pa
ct
s
Ku
m
ar
[3
7]
N
A
EN
M
s
M
ak
in
g
ac
as
ef
or
hu
m
an
he
al
th
ris
k-
ba
se
d
ra
nk
in
g
na
no
m
at
er
ia
ls
in
w
at
er
fo
rm
on
ito
rin
g
pu
rp
os
es
Ku
m
ar
et
al
.[
38
]
N
A
EN
M
s
Kn
ow
n,
un
kn
ow
ns
,a
nd
aw
ar
en
es
sr
el
at
ed
to
na
no
m
at
er
ia
ls
in
In
di
an
en
vi
ro
nm
en
t
Si
ng
h
an
d
Ku
m
ar
[3
9]
N
A
EN
M
s
Id
en
tif
yi
ng
kn
ow
le
dg
eg
ap
si
n
as
se
ss
in
g
he
al
th
ris
ks
du
et
o
ex
po
su
re
of
na
no
pa
rt
ic
le
sf
ro
m
co
nt
am
in
at
ed
ed
ib
le
pl
an
ts
K
ha
nn
aa
nd
Ku
m
ar
[4
0]
N
A
EN
M
s
In
clu
di
ng
na
no
m
at
er
ia
ls
m
ix
tu
re
si
n
hu
m
an
he
al
th
ris
k
as
se
ss
m
en
t
Fr
at
er
et
al
.[
41
]
N
A
EN
M
s
A
m
ul
tis
ta
ke
ho
ld
er
pe
rs
pe
ct
iv
eo
n
th
eu
se
of
al
te
rn
at
iv
et
es
ts
tr
at
eg
ie
sf
or
na
no
m
at
er
ia
l
sa
fe
ty
as
se
ss
m
en
t
Sa
vo
la
in
en
et
al
.[
42
]
N
A
EN
M
s
N
an
os
af
et
y
in
Eu
ro
pe
20
15
–2
02
5:
to
w
ar
ds
sa
fe
an
d
su
sta
in
ab
le
na
no
m
at
er
ia
ls
an
d
na
no
te
ch
no
lo
gy
in
no
va
tio
ns
St
on
ee
ta
l.
[4
3]
N
A
EN
M
s
Pr
io
rit
isi
ng
na
no
sa
fe
ty
re
se
ar
ch
to
de
ve
lo
p
as
ta
ke
ho
ld
er
-d
riv
en
in
te
lli
ge
nt
te
st
in
g
st
ra
te
gy
H
H
RA
:h
um
an
he
al
th
ris
k
as
se
ss
m
en
t;
N
A
:n
ot
ap
pl
ic
ab
le
;E
N
M
:e
ng
in
ee
re
d
na
no
m
at
er
ia
l.
4 Journal of Nanomaterials
3.2. Applications of ENMs. The list of areas of human
endeavour to which nanomaterials have been applied is
growing rapidly. Many of these applications are a result of the
special properties of nanomaterials such as their electrical,
catalytic,mechanical, surface plasmon resonance and antimi-
crobial properties [5, 57]. Some applications include sensors,
thermoelectric materials, photocatalysts, dye-sensitised solar
cells, and products such as paints, plastics, sprays, clean-
ing agents, coatings, sunscreens, films, packing materials,
nutraceuticals, and materials for drug delivery to name a few
(see, e.g., Sadik et al. [48] andGoesmann andFledmann [58]).
Exposure to nanomaterials may occur during the fabrication
and various application and disposal stages of the ENM-
containing products, as discussed in Section 4.
4. Assessment of Exposure to ENMs
To assess human exposure to ENMs during the different
stages of the life cycle of ENM-containing products, there is
need to estimate their quantities when released to the envi-
ronment together with toxicity-related parameters such as
their size, morphology, and chemical composition. Although
the field of ENM monitoring is yet not established, it draws
from the existing detection and characterisation methods
for monitoring particle pollution (e.g., measuring airborne
nanoparticles in the air).
Inhalation of airborne ENMs is one the most important
routes of entrance into the human body [59]. This is because
these nanosized particles suspended in the air can spread over
long distances from the point of their release, resulting in
uncontrollable human exposure. ENMs can also be disposed
to the environment in liquid suspensions (e.g., wastewater)
and in solidmedia (i.e., wastewater sludge). Human exposure
to ENMs from liquid and solid media is possible through
swallowing or direct contact with the skin. Human exposure
to the ENMs released into the terrestrial environment is less
likely to occur, mainly due to their immobility.
4.1. Measuring ENMs in the Air. Nanosized particles can be
released into the breathing air by both exhaust [50, 60–64]
and nonexhaust sources [60, 62, 65–68]. These nanoscale
particles undergo a number of physiochemical transforma-
tions [69, 70], resulting in both spatial and temporal variation
in their concentrations in both indoor [71–74] and outdoor
[69, 70, 75] ambient environments. Nevertheless, it is still
challenging to apportion the fraction of the ENMs in the total
nanoscale particulate material present in the atmospheric
environment [67].
The optical and electrical mobility detection tech-
niques used to measure the natural and combustion-derived
nanoparticles in ambient air are also used to measure the
concentration of ENMs [50]. Optical techniques rely on the
growth of nanomaterials by means of condensation and their
subsequent counting by measuring the light they can scatter.
The condensation particle counters (CPCs [76]) are widely
used for monitoring and research purposes. Although CPCs
can measure extremely low concentrations, their detection
efficiency decreases markedly for materials having diameters
below ∼3 nm [77].
An alternative to optical counting is to measure the
current produced by particles having a known charge distri-
bution using an aerosol electrometer (AE [78]). The number
concentration of the sampled nanomaterials can be estimated
using the current inducted by the collection of the charged
particles on an electrometer filter, the flow rate through
the AE, and the charge distribution on the particles. The
charge distribution of particles can be controlled by using an
aerosol particle charger [79] operating upstream of the AE.
Compared to the CPCs, the AEs can detect particles of any
size. However, the threshold concentration for producing a
signal above the signal-to-noise ratio is of the order of a few
tens to hundreds of particles per cm3 for typical flow rates
used through the AEs.
Sizing of particles in the gas phase can be achieved by a
number of techniques depending on the desired range [80].
The most efficient instrument for determining the size of
particles in the nanosize regime is the differential mobility
analyzer (DMA [81]). DMAs classify airborne particles based
on their electrical mobility, which by knowing the charge
distribution and the morphology of the particles can be used
to estimate their size. Although a wide range of DMA designs
have been described in the literature [82], the cylindrical
DMA is routinely used in combination with CPCs for
measuring aerosol particle size distribution. To do so, the
operating conditions (mainly the electric field strength) of
the DMAs are increased in steps or continuously scanned
to select particles of different sizes before being counted by
the CPC. Typical scanning times of these systems take from
a few seconds to a few minutes, depending on the desired
resolution of the measurements [83]. Recent advances in the
field have led to DMAs [84–86] and mobility spectrometers
[50, 79] that can simultaneously classify particles in different
size ranges, thereby reducing the time required to measure
the entire size distribution of the particles in subsecond time
fractions.
The pulmonary toxic effects induced by inhalation of
ENMs are best correlated with the surface area rather than
the concentration of the particles [87]. Instruments that can
directly measure the surface rather than the number or the
mass of the particles are already available in themarket.These
instruments rely on the attachment of ions or radioactive
species onto the surface of particles and measuring of their
current or radioactivity, respectively [88, 89]. In accordance
with recent guidelines defining benchmarks or reference
threshold values, surface area monitors that rely on the
attachment of ions on the particles are also used to determine
the mean particle diameter and the number concentration
under the assumption that those are spherical [90]. Given that
many types of nanomaterials do not have a spherical shape,
the estimation of the surface area by these instruments can be
misleading.
One of the greatest challenges in monitoring the con-
centration of ENMs in the air is to distinguish them from
already present background nanomaterials, which can also
vary in concentration, size, morphology, and composition,
depending on the nature of natural and anthropogenic
sources. Online distinction between engineered and back-
ground nanomaterials can be made by probing their intrinsic
Journal of Nanomaterials 5
properties such as morphology, solubility, and volatility,
provided that these are detectably different among the two
species. Tandem differential mobility analysis (TDMA [91])
can also be used to measure the intrinsic properties of
particles such as morphology, vapour uptake, and volatility
[92, 93]. Information on the chemical composition or the
structure of the airborne nanomaterials can also be obtained
by offline techniques such as electron microscopy [94]. Elec-
tron microscopes can also be used for determining the ele-
mental composition of nanoparticles, using techniques such
as electron dispersive X-ray (EDX) spectrometry [95, 96].
These techniques, however, are time-consuming, expensive,
of high complexity, and therefore inappropriate for systematic
monitoring.
4.2. Measuring ENMs in the Aquatic Environment. Methods
for characterising nanomaterials suspended in liquid media
have been developed over the past decades in view of
monitoring and controlling their synthesis by liquid-based
techniques. Dynamic light scattering (DLS) is the most
widely used technique for measuring the size and shape of
nanoparticles in liquid suspensions [97]. In DLS, the solution
sample is illuminated by a monochromatic light source, and
the light scattered by the particles is continuously measured
by a photodetector. The recorded scattering fluctuations are
then processed in order to determine the translational and
rotational diffusion coefficients of the particles, which in turn
are used to determine their size and shape [98]. A drawback
of DLS is that the larger particles in the samples can mask
the signal from the nanoparticles during the measurement
[99]. Another drawback is that they are not suitable for the
assessment of nanofibres or nanorods.
Another way of measuring the size distribution of
nanoparticles in liquid suspensions is by tracking and
analysing theirmotion.Nanoparticle tracking analysis (NTA)
measures the scattering generated from particles undergoing
Brownian motion in order to estimate their diffusion coeffi-
cients [100]. Although the signal of the larger particles inNTA
can also mask the signal produced by the smaller particles
due to their stronger scattering, the effect is less important
than in the DLS [101]. As a result NTA is preferred to DLS for
measuring nanosized particles.
Another technique for measuring particles with diam-
eters down to the nanometer size range is flow field-flow
fractionation (flow FFF [102]). In Flow FFF, the particles are
separated in a crossflow channel, where larger particles are
immobilised in an expanding channel faster than the smaller
ones due to differences in their diffusivity [103]. A variation
of this method is the asymmetric flow FFF (AF4), which is
capable of fractionating particles andmacromolecules having
diameters down to 2 nm [104]. AF4 can separate particles
with high resolution, thereby giving unique characterisation
possibilities for nanoparticles suspended in liquid media.
5. Hazard Assessment
5.1. Toxicity Data Availability. Many studies are currently
focusing on understanding toxic effects of ENMs in in
vitro and in vivo studies on different species (rats, fishes,
algae, daphnids, and bacteria, amongst others). Among these
studies, rats as animalmodels are used for obtaining reference
doses. Very few toxicity studies are currently available which
provide complete information on experimental conditions
(i.e., nanoparticles characteristics, animal- or cell line-related
information, exposure duration and frequency, and exposure
medium and endpoints observed). To illustrate this aspect,
summary of toxicity studies on nano-TiO
2
-based ENMs for
oral and inhalation exposure routes is presented in Tables 2
and 3, respectively. Review of these studies indicates that
different works have used varying experimental conditions
and endpoints for observing effects, making it challenging
to obtain data for systematic comparison and risk estimation
purposes. For example, there is a lack of detailed dataset
from toxicological and epidemiological studies on inhalation
toxicity to humans. To circumvent this issue, animal data
are used for determining toxicity parameters for human
external and lung doses [44]. Although use of animal data
for reference dose quantification is a standard methodol-
ogy in the absence of toxicity data on humans, there is
inherent uncertainty in extrapolating findings on animals
to humans (i.e., interspecies uncertainty). Further, there
exists a difficulty in finding out toxicity studies with detailed
information on experimental descriptions for comparison
purposes. For example, O’Brien andCummins [105] screened
many studies of TiO
2
particles to identify toxicity works that
are suitable for providing ingestion and inhalation-related
animal data. After a thorough review, they were able to
finally use findings from the following studies related to (i)
inhalation (endpoint: lactate dehydrogenase (LDH) test [106–
108]) and (ii) ingestion (endpoint: liver kidney and spleen
coefficient; blood biomarker assays and histopathological
examination [109]). These observations clearly indicate a
need for standardising toxicity conditions for observing a
given endpoint and facilitating easy comparison of toxicity
data [110]. During the use of animal toxicity data, there is
also a need for the accounting of the effects of animal species
or strain on toxic effects and subsequently on dose-response
parameters. For example, Kuempel et al. [44] discussed the
exposure of ultrafine and fine TiO
2
particles to rat strains
(Sprague-Dawley,Wistar, Fischer 344, and Long Evans).They
found a difference in observed lung burden doses, indicating
a need to consider the effect of rat strain type on dose-
response parameter since this can influence benchmark dose
limit values that are normally calculated using dose-response
data.
Furthermore, some researchers have studied ENM-based
toxicity on cell lines (see Tables 2 and 3). These studies are
easier to conduct than in vivo studies. However, findings of in
vitro studies cannot be directly used to understand toxicity
of ENMs to the target organs as toxic effects on cell lines
cannot represent toxic effects on the whole target organ.
These data are sometimes less useful than those obtained
from animal models (e.g., rats) as findings of toxicity studies
on cells cannot be easily extrapolated for determining toxicity
to either human cell line or to human target organ. However,
this step is not required if toxicity data is directly available
for human cell line and/or human organs. There is a need
for identifying mechanisms for extrapolating the findings of
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Table 2: Oral toxicity of TiO2 to rats and in vitro data on rat cell lines.
Reference Exposed animals/cell line type Experimental design Endpoint
Hussain et al. [111] BRL 3A rat liver cell line Exposure of TiO2 particles for 24 hoursin vitro to 40 nm TiO2 particles
Cytotoxicity; mitochondrial function
Trouiller et al. [13] Rats
Exposure of TiO2 particles (21 nm size,
75% anatase, and 25% rutile) through
drinking water
DNA single and double strand breakage;
chromosomal damage in vivo; DNA
deletions in offspring
Kocbek et al. [112] HEK cells Effect of TiO2 and ZnO particles on HEKcells in vitro Cytotoxicity
ENM: engineered nanomaterial; HEK cells: human embryonic kidney cells; ROS: reactive oxygen species.
Table 3: Inhalation toxicity of TiO2 to rats and in vitro data on rat cell lines.
Reference Exposed animals/cellline Experimental design Endpoint
Henrich et al. [113] Wistar rats;inhalation
Chronic inhalation (24 months); 10mg/m3
TiO2 particles (15–40 nm size; mass-median
aerodynamic diameter = 800 nm)
Carcinogenicity; histology; DNA addicts;
alveolar lung clearance
Bermudez et al. [106] Hamster and rat;inhalation
Subchronic inhalation (3.25 months);
10–250mg/m3 pigmentary TiO2 particles
(assumed diameter = 300 nm; mass-median
aerodynamic diameter = 1400 nm)
Inflammatory response; cytotoxicity; lung
cell proliferation; histopathology
Ho¨hr et al. [108] Rat; instillation 16 h instillation; 1–6mg (diameter =20–30 nm and 180 nm)
Acute inflammatory response; cell
damage
Bermudez et al. [107] Hamster and rat;inhalation
Subchronic inhalation (13 weeks);
0.5–10mg/m3; diameter = 21 nm;
mass-median aerodynamic
diameter = 1370 nm)
Inflammatory response; cytotoxicity; lung
cell proliferation; histopathology
Renwick et al. [114] Rat; instillation 24 h instillation; 0.125–0.5mg(diameter = 29 nm and 250 nm)
Inflammatory response; epithelial injury;
alveolar macrophage toxicity; lung
clearance
Warheit et al. [115] Rat; instillation
24 h, 1-week, 1-month, and 3-month
instillation; 129.4 nm; 149.4 nm; 136 nm;
382 nm
Bronchoalveolar lavage (BAL) fluid
inflammatory markers; cell proliferation;
histopathology
Grassian et al. [116] Rat; inhalation 4 h duration and 10-day duration; 3.5 nm Total protein content; LDH activity;inflammatory cytokines; histopathology
Li et al. [117] Rat; inhalation Three-day inhalation; 3 nm; 20 nm BAL fluid biochemical parameters;histopathology
Lui et al. [118] Rat; instillation One-week instillation; 5–50 nm
Histopathology; blood biochemical
parameters; LDH, alkaline phosphatase,
and acid phosphatase activity; alveolar
macrophage phagocytotic ability
Falck et al. [56] Bronchial cells(BEAS 2B)
Exposure to 8 doses (1–100𝜇g/cm2) of TiO2
particles: (1) nanorutile, (2) anatase with size
<25 nm, and (3) fine rutile with size <5𝜇m
for 24, 28, and 72 hours of exposure
DNA damage
Bhattacharya et al. [20] Bronchial cells(human BEAS 2B)
Toxicity of TiO2 particles in anatase crystal
phase (size: <100 nm)
Reactive oxygen species (ROS)
production; DNA adduct formation
Bhattacharya et al. [20] Lung fibroblast cells(IMR-90)
Toxicity of TiO2 particles in anatase crystal
phase (size: <100 nm) Cytotoxicity
in vitro studies to in vivo studies. In this direction, some
studies have used an endpoint that can be easily compared in
in vitro and in vivo toxicity studies. For example, Faux et al.
[119] used pulmonary inflammation as a response function
for toxicity to epithelial cells in the centriacinar region of the
lungs and in a petri dish. They reported that in vivo response
(i.e., an increase in polymorphonuclear leukocytes in bron-
choalveolar lavage fluid from rats) and in vitro response (i.e.,
an increase in inflammatory cytokine interleukin-8 mRNA
in human alveolar epithelial cell line A549) were found to
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be comparable. More studies are required to explore this
approach which can increase the usefulness of in vitro studies
in the interest of time and cost.
On the other hand, recent studies are also considering
the prospects of using alternative test methods to understand
health risk and toxic effects of different chemicals. For
example, the U.S. National Research Council’s report [120]
focuses on toxicity of chemicals to humans and suggests
using alternative test methods to improve understanding.
Studies are exploring suitability of alternative test methods
(high throughput systems, in silico and in vitro models) for
screening large number of samples containing ENMs and for
reducing increased burden on animal testing [41, 43, 120]. For
example, Frater et al. [41] applied predictive modelling and in
vitromodelling for selecting carbon nanotubes in short-term
inhalation or instillation studies. Similarly, Puzyn et al. [121]
used experimental testing and quantum-mechanics-based
computational modeling for studying cytotoxicity of metal
oxide nanoparticles to E. coli. These recent efforts indicate
the feasibility of using alternative test methods for toxicity
studies in order to obtain data relevant to the dose-response
step. These methods have also been mentioned in European
Parliament and Council directives [122, 123]. However, more
efforts are clearly needed to improve toxicity screening of
increasing number of nanomaterials.
5.2. Effect of Physiochemical Characteristics of ENMs on
Toxicity. Physical and chemical properties of the ENMs have
been shown to influence their toxicity [124–127]. There is
currently a need for additional data providing information
on the effects of ENMs characteristics (i.e., size, shape,
chemical composition, and degree of agglomeration) on
their toxicity [44]. ENM size in the environment depends
on media characteristics. For example, ENM size in water
depends on water physicochemical characteristics, such as
ionic strength, pH solution, and presence of other co-ions
[128].Therefore the size of the ENMs needs to be determined
in the exposure media and this needs to be related to the
results from the hazard studies. Some studies have assessed
the effect of size on ENM-induced toxicities to determine
size-dependent dose-response model of ENMs for a given
endpoint. For example, Falck et al. [56] observed that the
lowest dose inducing DNA damage on bronchial cells BEAS
2B is 1 𝜇g/cm2 for fine rutile, 10 𝜇g/cm2 for nanoanatase,
and 80 𝜇g/cm2 for nanorutile (see Table 2). Furthermore,
particle size also affects extent of deposition in lungs during
inhalation and its subsequent deposition in lungs and other
organs as noted in Table 3 [44, 124]. For example, clearance
of nanoparticles was found to be smaller than that of larger
particles during inhalation exposure [124–126]. The finding
of the Falck et al. [56] study also indicated the effect of
crystallinity of nanoparticles on lowest dose inducing DNA
damage. Further, chemical composition of ENMs also affects
the extent of their toxicity [29]. For example, extent of toxicity
of TiO
2
and Ag nanoparticles differ for a given media. This
information highlights the effects of size, shape, phase, and
chemical composition on toxicity of ENMs and indicates
a need for incorporating these factors into estimating the
ENM-based toxicity reference limits for animal and human
exposure.
5.3. Nanomaterials Cooccurrence. There exists a possibility
of cooccurrence of ENMs in the environment, indicating a
chance of exposure to different types of ENMs simultane-
ously. To estimate human health risks due to exposure of
more than one type of ENM in the environment, related
toxicity data are required. Although data on exposure of indi-
vidual ENMs to animals and human cell lines are available,
data are still lacking on the effect of interaction with other
chemicals and any possible subsequent synergistic or antag-
onistic effects on different target organs/organisms [40]. For
example, Gou et al. [129] noted that synergism between the
ENMs made of Ag and TiO
2
is plausible on bacteria. As this
study was conducted on bacteria, the obtained information
about interaction of Ag and TiO
2
particles cannot be used in
EHHRA. To properly incorporate exposure of more than one
type of ENM, information about cooccurrence of different
ENMs in a given medium, chances of exposure of more than
one type of ENM from a given exposuremedium, and data on
toxicity due to mixture of ENMs for a given target organ are
required. For example, carbon nanotubes and fullerenes are
emitted into the environment during combustion processes
and coexist in air [130]. Both of these carbon-based ENMs
affect alveoli region of lungs. A review by Aschberger et al.
[131] indicates that toxicity studies are available only for
carbon nanotubes or for fullerenes. However, these two
types of carbon-based nanomaterials have not been studied
together in toxicity studies. The information about effects of
possible interactions of two or more than two ENMs on a
given target organ need to be gathered to determine resultant
dose-response curves.
Currently, the conventional approach is to develop dose-
response curves for a given endpoint using exposure of
single type of contaminant. To account for toxicity due to
cooccurring ENMs, one simplified approach could be to
use reference values of exposure of single ENMs to target
organ without assuming interaction with the other types
of ENMs. It is similar to the USEPA’s dose-addition-based
risk assessment methodology [46, 132]. This methodology
assumes that contaminants in mixture behaves similarly to
how they would behave if they were present individually in
water [45, 46]. However, this approach might not capture
the realistic effect of action on site, and two or more ENMs
might be affecting. Towards this, the first attempt could be
made by calculating the USEPA’s interaction-based hazard
index (HI), as seen in (1) [46, 132], for a mixture of ENMs.
The HI is generally used for chemicals. In (1), HQ
𝑖
is hazard
quotient for 𝑖th chemical; 𝑓
𝑖𝑗
is toxic hazard of the 𝑗th
chemical relative to the total hazard from all chemicals
potentially interacting with 𝑖th chemical. The magnitude
of interaction between chemicals is represented by 𝑀
𝑖𝑗
(an
interaction magnitude parameter, default value = 5 [46]).
The strength of evidence that 𝑖th chemical influences the
toxicity of 𝑗th chemical is represented by 𝐵
𝑖𝑗
(i.e., weight-of-
evidence factor (2a)). Also, 𝑔
𝑖𝑗
in (1) indicates a degree to
which 𝑖th chemical and 𝑗th chemical are present in equitoxic
amounts (2b). For the case of two chemicals, 𝑓 value is
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1 as HQ
12
= HQ
2
/[HIadd −HQ1] = HQ2/[HQ2]. B can be
assigned to default value of 0.5 based on guidelines from the
USEPA [46] methodology, as also used by studies elsewhere
[133, 134].
HIint =
𝑛
∑
𝑖=1
HQ
𝑖
𝑛
∑
𝑗 ̸= 𝑖
(𝑓
𝑖𝑗
×𝑀
𝑖𝑗
𝐵𝑖𝑗×𝑔𝑖𝑗) . (1)
𝑓
𝑖𝑗
=
HQ
𝑗
HIadd −HQ𝑖
(2a)
𝑔
𝑖𝑗
=
√HQ𝑖 ×HQ𝑗
0.5 × (HQ
𝑖
+HQ
𝑗
)
. (2b)
The USEPA’s risk assessment methodology for chemicals for
estimating risks can only be used for estimating risks due to
exposure of mixture of ENMs provided this equation holds
true for ENMs mixture as well. Currently, not much work
has been conducted to understand applicability of (1) and
((2a) and (2b)) in this regard. The first step towards this
approach is to gather information about all parameters used
in these two equations.The following steps are encouraged to
modify current ENM-related occurrence and toxicity studies:
(i) calculate the chance of cooccurrence of different ENMs in
a given medium, (ii) develop groups of cooccurring ENMs
influencing a given endpoint, and (iii) obtain dose-response
data during simultaneous exposure of two or more ENMs to
target models under study if available or conduct studies to
obtain these data to assess the effect of cooccurrence of ENMs
on toxicity endpoints. Using this additional information, the
USEPA methodology for mixture of chemicals ((1), (2a) and
(2b)) may be applied to estimate risks due to exposure of
ENMs, until detailed methodology for mixture of ENMs is
available.
5.4. Fate of ENMs inOrganisms and Translocation Assessment.
Inhaled or ingested ENMs could be translocated to different
parts of the body through systemic distribution [135]. As
a result, the exposure of ENMs from one particular route
might result in exposure of ENMs to different organs. Thus,
exposure assessment and dose-response assessment stages
need to consider this aspect for assessing overall toxicity from
a given exposure route.
During inhalation exposure, ENMs may deposit in lungs
where they may disaggregate into smaller particles in the
alveolar lining fluid, resulting in exposure of both nanosize
and micron-size particles to interior parts of the lungs [136].
Once particles are deposited in the respiratory tract, clearance
mechanisms such asmucociliary clearance in airways or alve-
olar macrophage-mediated clearance in gas-exchange region
govern deposition, clearance, and translocation of particles
to other regions [124–126]. This translocation happens when
particles enter in the lymph or blood circulation. Thus, the
ENMs exposed through inhalation route reach to lungs as
well as in other organs.
Similar observations have been found in the case of
oral exposure of ENMs. For example, the biodistribution
experiment by Wang et al. [137] on adult mice showed that
orally administered TiO
2
was found to be retained mainly
in the liver, spleen, kidneys, and lung tissues, indicating
translocation of TiO
2
particles to other tissues and organs
after uptake by gastrointestinal tract. The work of Park et al.
[138] reported that, when mice were orally treated with
1mg/kg Ag particles for 14 days, small-sized Ag particles
(22 nm, 42 nm, and 71 nm) were found to be distributed to
brain, lung, liver, kidney, and testis. However, large-sized Ag
particles (323 nm) were not detected in these organ tissues,
indicating an effect of size on translocation. Furthermore, a
recent study by van der Zande et al. [139] noticed in vivo
formation of silver nanoparticles in rat organs during their
oral exposure to silver salts over a study duration of 28 days.
These findings indicate the possibility of in vivo formation
of nanoparticles, which also needs to be considered in
estimating exposure dose of nanoparticles in risk assessment
process.
5.5. Toxicity Study Duration. Although data from acute- or
subchronic studies on animal toxicity studies [13, 140] are
available, they do not represent fully the toxicity of ENMs to
target organs during long-term exposure. Thus, uncertainty
on extrapolation from subchronic to chronic exposure data
still exists. As chronic studies are expensive, there is a need
for developing short-term tests to simulate chronic exposure
scenario. In these studies, biological indictorswhose response
can be extended based on causal relationship for long-term
exposure need to be explored in detail [44]. In addition, there
could be differences in toxicodynamics and toxicokinetic
response in short- and long-term studies during the use of
low concentration of ENMs, which need to be considered in
these short-term tests. Overall, there is a need for conducting
more long-term toxicity studies or combining experimental
data [29] and simulation-based hybrid approach to predict
long-term toxicity effects.
5.6. Quantitative Nanostructure-Toxicity Relationship
(QNTR). Quantitative structure-activity relationship
(QSAR) has been widely used in pharmacology and related
fields to predict the toxicity of drugs without the need for
tedious, time-consuming, and expensive animal testing.
An analogue of the model, QNTR, has been extended to
nanomaterials. In this context, Winkler et al. [141] recently
noted that structural properties of nanomaterials, which
influence toxicity, may include size, shape, surface area, and
degree of electrostatic interaction between nanomaterials and
their cellular environments as well as other physicochemical
properties of nanomaterials. These properties have been
used as descriptors [121, 141, 142] for the prediction of the
properties of new materials or for the explaining of their
biological effects. In many instances, such predictions are
facilitated by the use of multivariate data analysis techniques
including regression models and artificial neural networks
and verified by cross-validation, using training and validation
data sets [143].
Emerging results from these types of studies indicate
that the structural properties, which influence the toxicity
of nanomaterials, can reside both in the core and on the
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surface of the materials [141, 144]. However, to extend QSAR
to QNTR effectively, a number of challenges need to be
addressed. Winkler et al. [141] have mentioned some of these
challenges as
(i) lack of adequate definition and understanding of
the biologically important entities that moderate the
adverse effects of nanomaterials,
(ii) need to choose the right assays that can be used to
model and correlate the toxic effects of nanomaterials
in vitro and in vivo,
(iii) accurate modeling of the complex interactions
between nanomaterials and biological systems,
(iv) understanding of the relationship between QNTR
methods and other computational approaches such as
quantum chemistry and molecular dynamics.
These challenges arise due to following data gaps: (i) lack of
sufficient empirical data on the composition of biocorona on
the surfaces of nanomaterials; (ii) lack of in vitro data that
can be used to predict in vivo effects of nanomaterials, and
(iii) the paucity of descriptors that can specifically be used
for nanomaterials [141]. Despite these challenges and data
gaps, progress has been made in probing and understanding
the interactions of nanomaterials with their biological envi-
ronments. For example, Lynch and Dawson [145] described
the use, strengths, and shortcomings of surface plasmon
resonance, magnetic nanosensor arrays, surface adsorption
index, isothermal titration calorimetry, shotgun proteomics
analysis, fluorescence correlation spectroscopy, size exclusion
chromatography, and liquid chromatography-tandem mass
spectrometry in increasing the understanding of the interac-
tion of nanomaterials with environmental molecules.
However, the gaps in knowledge must be fully identified
and understood before an internationally acceptable
approach to QNTR is proposed, which can appeal to
all stakeholders. An important initiative taken towards
achieving this goal was captured by a recent workshop
(http://www.cost.eu/events/qntr) on the use of QNTR
methods in modelling the biological effects of nanomaterials.
This workshop highlighted the challenges envisaged and
the proposed methods of overcoming these challenges.
It also proposed short- to long-term steps that could be
taken to address the challenges (Table 4). In a similar
development, Stone et al. [43] reported that a European
Commission funded a project, which was undertaken to
identify the framework of future research priorities for
the development of an intelligent testing strategy (ITS) for
evaluating nanomaterials safety without the need for case-
by-case assessment of human and environmental exposure.
Some short-, medium-, and long-term research priorities
emanating from the project are also included in Table 4.
Readers interested in the full report are encouraged to visit
http://www.nano.hw.ac.uk/research-projects/itsnano.html
[43].
6. Environmental Regulations of ENMs
A review of literature indicates that not much information is
available on the regulation of ENM-related exposure [8, 67].
The scope of different available regulations and guidelines in
the USA, European Union, and WHO is limited to organic
compounds and toxic substances, but they do not specifically
address ENM-related pollution. Air quality directives set by
the US Environmental Protection Agency (USEPA) and the
European Commission (EC) include concentration limits
for particulate pollution [146, 147]. These limits, however,
refer to mass concentration measurements (i.e., PM
10
and
PM
2.5
), which are not appropriate for airborne nanoparticles
[75, 148]. Some studies have attempted to understand the
suitability of current regulations in handling ENM pollution.
For example, Beaudrie et al. [110] analysed U.S. Federal
Environmental, Health, and Safety (EHS) regulations for
their adequacy and application to ENMs using a life-cycle
framework. They found that existing regulations for con-
trolling occupational exposure and environmental pollution
(e.g., the OSHA Act, the Clean Air Act, and the Clean Water
Act) do not provide provisions for addressing regulation of
ENM-related environmental pollution. Finding of this study
indicated that there is a need for investigating suitability of
current regulations for controlling environmental pollution
of ENMs. As the development of environmental regulation
for ENMs is still undergoing, regulatory bodies of some
countries such as the US [95], UK [41, 120], and Australia [62,
63] are investigating if ENM-based products could be treated
as new classes of existing substances, which are currently
being regulated. Towards this, many countries have started
collecting nanospecific data from each product and building
a database so that it can be used in regulating ENMs. For
example, the US is collecting substance-specific information
for ENMs from different products for regulating ENMs [149].
It appears that regulatory bodies may continue to use existing
regulations to address ENM pollution until ENM-related
regulation is structured and approved. In this regard, some
studies have suggested communication of nanospecific infor-
mation of products to all stakeholders (manufacturers, users,
and regulatory bodies) in an effective manner. For example,
Nowack et al. [150] analysed release and behaviour of ENMs
for the context of major accident prevention and suggested to
include nanospecific data in material safety data sheets on a
compulsory basis. Furthermore, a notable amount of current
research is focusing on prioritising ENM-related research
issues and exposure metrics to develop stakeholder-driven
intelligent testingmethods and strategies. For example, recent
work of Stone et al. [43] used opinions of experts from
government, academia, industry, funders, and NGOs for
systematically identifying a need for information in the areas
of physicochemical characterisation, exposure identification,
and hazard identification and modelling approaches for
short-, medium-, and long-term time scales. There is clearly
a need for initiating regulatory efforts to develop guidelines
and monitoring metrics for regulating the presence of ENMs
in water, air, and soil media. Whether these limits should be
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Table 4: Desirable (achievable) outcomes of quantitative nanostructure-toxicity relationship (QNTR) in the next ten years adapted from
published studies (Winkler et al. [141]; Stone et al. [43]).
Short-term Medium-term Long-term
(i) Fully characterised nanomaterials that can
be used in experiments
(i) Appreciable data on in vivo effects
of nanomaterials
(i) Sufficient in vitro and in vivo information on
nanomaterials to assist the development of
regulatory measures
(ii) In vitro assays that are useful for the
assessment of toxicologically relevant effects
(ii) Robust in vivomodels for
predicting the endpoints of
nanomaterials’ interaction with
biological systems
(ii) Reliable models for prediction and
risk-based classification of nanomaterials
(iii) Fast and highly efficient methods for
measuring and modelling the interaction of
nanomaterials with biological systems
(iii) In-depth understanding of the
mechanism of nanomaterials toxicity
(iii) Integration of the data into legal
framework, life-cycle assessment, and decision
trees
(iv) Specific descriptors for modelling the
relationships among the structures and
toxicity properties of nanomaterials
(iv) Information on cohort and
population; direct and indirect;
short-/long-term reversible and
irreversible effects
(iv) Implementation of risk assessment
frameworks
based on number,mass or surface area concentrations are still
contentious [8].
7. Summary, Conclusions, and
Future Directions
This article provides current status of knowledge in areas
of measurements, characterisation, and environmental risk
assessment of the ENMs besides identifying the research gaps
and future directions. The proposed future steps could help
in (i) providing information about monitoring of ENMs and
dose-response parameters reflecting environmental exposure
conditions, and (ii) developingQNTR.The summary and key
conclusions on the topic areas covered are listed below.
(i) The field of ENM monitoring is yet fairly new
and therefore the monitoring methods are generally
adopted from the existing techniques for monitoring
particle pollution in air and water environments. The
greatest challenge in monitoring the concentration
of ENMs in any environment is to distinguish them
from the background nanomaterials.
(ii) Methods are available for measuring particle number
concentration and characteristics. Particle concen-
tration and size distribution can be measured using
instruments such as DLS, CPC, DMPS, FMPS, ELPI,
and SMPS. Surface characterisation of nanomaterials
is generally conducted using SEM, TEM, EDX, BET,
TG, FTIR, near-infrared, and Raman’s spectroscopy
methods. These methods are usually complicated,
time-consuming, and expensive, thereby making
them inappropriate for routine monitoring of ENMs
in different environmental media.
(iii) Current toxicity studies do not use realistic expo-
sure conditions during dose-response experiments
and hence these are inappropriate for the EHHRA
of ENMs. In addition, recent studies have started
developing relationships between structural proper-
ties of nanomaterials and toxicity (i.e., QNTR) for
use in the dose-response step. However, this approach
needs extensive empirical data on physicochemical
characteristics and toxicity of ENMs. Such data are
currently unavailable in abundance and need to be
systematically obtained.
(iv) In order to address mixture toxicity issue in the
EHHRA of ENMs, the following steps are proposed.
(i) Calculate chances of cooccurrence of different
ENMs in a given medium. (ii) Develop groups of
cooccurring ENMs influencing a given endpoint.
(iii) Obtain dose-response data during simultaneous
exposure of two or more ENMs to target cell line
or target organ or animal used in toxicity studies.
And (iv) use the USEPA methodology for mixture of
chemicals for conducting risk estimation of exposure
of ENMs until detailed methodology for mixture of
ENMs is available. These steps need to be pursued for
investigating their appropriateness in assessing health
risks due to exposure to ENMs.
(v) Despite increased awareness in public and recent
reporting of ENMs in environment, not much infor-
mation is yet available to regulate them due to the
continuing technical difficulties.
Figure 1 presents the interlinking of identified factors
affecting the EHHRA of ENMs. The following directions for
future research works can assist in filling the research gaps on
the topic areas covered:
(i) developing a combination of different analytical
methods for determining ENM mass concentration,
particle concentration, and morphological informa-
tion,
(ii) conducting toxicity studies using conditions relevant
to environmental exposure of ENMs for humans to
obtain dose-response information useful in EHHRA
of ENMs,
(iii) obtaining relevant data in order to develop QNTR
relationships,
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Figure 1: Schematic showing interlinkages of different factors for determining environmental and health risks due to ENM exposure.
(iv) initiating efforts for formulating guidelines for regu-
lating presence of ENMs in different environmental
media.
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